D61.1 is the ICD-10 code for Drug-induced aplastic anaemia. It is a four-character subcategory of D61 (Other aplastic anaemias), the most specific level in the WHO edition. It belongs to the block D60–D64 (Aplastic and other anaemias) in Chapter III, Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism.
- Code type
- Subcategory (4 characters)
- Chapter
- III · D50–D89
- Classification
- WHO ICD-10, 2019 version
Coding notes
- Use additional external cause code (Chapter XX), if desired, to identify drug.
D61.1 in national editions
Countries report with their own edition of ICD-10. Most keep the WHO code and add more specific codes beneath it.
D61.1Legemiddelutløst aplastisk anemi
DD611Aplastisk anæmi forårsaget af lægemiddel
D61.1Arzneimittelinduzierte aplastische Anämie
- D61.10Aplastische Anämie infolge zytostatischer Therapie
- D61.18Sonstige arzneimittelinduzierte aplastische Anämie
- D61.19Arzneimittelinduzierte aplastische Anämie, nicht näher bezeichnet
D61.1Aplasie médullaire médicamenteuse
D61.1door geneesmiddelen geïnduceerde aplastische anemie
D61.1Drug-induced aplastic anemia
Based on the World Health Organization’s International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10), 2019 version, and the national editions published by each country’s health authority. This page is a reference, not coding advice; follow your national coding rules when you report.
Look up another code
Stop looking codes up by hand
Docdemic listens to the consultation, writes the note and suggests the diagnosis and procedure codes that fit it, each one checked against your country’s official code list.
Try Docdemic free